High-dose MTX-based chemo is well tolerated in older PCNSL patientsApril 24, 2019Lymphoma & Plasma Cell DisordersRare Diseases
Creating CAR T-cell therapies for T-cell malignanciesApril 16, 2019Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationImmunotherapyImmuno-oncologyRare Diseases
Bendamustine/rituximab combo proves viable for comorbid CLLApril 10, 2019Leukemia, Myelodysplasia, TransplantationRare Diseases
Genetic variant increases stroke risk in childhood cancer survivorsApril 2, 2019Patient & Survivor CarePediatricsRare Diseases
CAR T cells target HER2 expression in advanced sarcomasApril 1, 2019Sarcoma & GISTImmuno-oncologyRare Diseases
Case report may link gluteal implants to lymphomaMarch 12, 2019Lymphoma & Plasma Cell DisordersRare Diseases
Similar results for once- or twice-weekly carfilzomib in MMFebruary 23, 2019Lymphoma & Plasma Cell DisordersRare Diseases
Trial supports less aggressive myeloma treatmentFebruary 8, 2019Lymphoma & Plasma Cell DisordersRare Diseases
ALL chemotherapy looks effective in mixed phenotype leukemiaJanuary 3, 2019Leukemia, Myelodysplasia, TransplantationPediatricsRare Diseases
FDA approves Elzonris for blastic plasmacytoid dendritic cell neoplasmDecember 21, 2018Rare DiseasesLeukemia, Myelodysplasia, Transplantation
2018: A banner year for hematology drug approvalsDecember 5, 2018Mixed TopicsPractice ManagementLymphoma & Plasma Cell DisordersRare Diseases
